EWA
MDCX

EverSource Wealth Advisors’s Medicus Pharma MDCX Stock Holding History

EverSource Wealth Advisors’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$695 – 4490
2025
Q3 		$695 Buy
+300
New +$752 ﹤0.01% 3855

Other funds holding MDCX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

EverSource Wealth Advisors's MDCX Position: Q4 2025 in Review

EverSource Wealth Advisors sold out of Medicus Pharma (MDCX) in Q4 2025, closing a stake of 300 shares — an estimated $695 sold.

EverSource Wealth Advisors first reported a position in MDCX in Q3 2025 and held it in 1 quarter. The position peaked at $695 in Q3 2025. 21 funds tracked by Wall St. Rank hold MDCX as of Q4 2025.

  • EverSource Wealth Advisors reported no remaining Medicus Pharma position as of Q4 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 300 Medicus Pharma shares in Q4 2025, an estimated $695.
  • EverSource Wealth Advisors first reported a position in Medicus Pharma in Q3 2025 and held it in 1 quarter.
  • EverSource Wealth Advisors's Medicus Pharma position peaked at $695 in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Medicus Pharma as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.